Login to Your Account

MedImmune Offer Comes In High: AstraZeneca To Pay $15.2 Billion

By Jim Shrine

Tuesday, April 24, 2007
MedImmune Inc., which officially put itself up for sale less than two weeks ago, agreed Monday to be acquired by AstraZeneca plc for $15.2 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription